Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 3/20 | 0.34 |
| ▸ | CA2 | P00918 | 3/20 | 0.34 |
| ▸ | CA12 | O43570 | 2/20 | 0.34 |
| ▸ | CA9 | Q16790 | 2/20 | 0.34 |
| ▸ | NAAA | Q02083 | 2/20 | 0.34 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.33 |
| ▸ | ACHE | P22303 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1553827 | 0.80 | CA1 (0.44) | CA1CA2CA12CA9NAAA | |
| SCHEMBL29006344 | 0.78 | CA1 (0.37) | CA1CA2CA12CA9NAAA | |
| SCHEMBL28716435 | 0.78 | CA1 (0.37) | CA1CA2CA12CA9NAAA | |
| SCHEMBL30838778 | 0.78 | CA1 (0.37) | CA1CA2CA12CA9NAAA | |
| SCHEMBL29161823 | 0.78 | CA1 (0.37) | CA1CA2CA12CA9NAAA | |
| SCHEMBL12980150 | 0.78 | CA1 (0.33) | CA1CA2CA12CA9NAAA | |
| SCHEMBL2341384 | 0.78 | CA1 (0.37) | CA1CA2CA12CA9NAAA | |
| SCHEMBL29433 | 0.78 | CA1 (0.42) | CA1CA2CA12CA9NAAA | |
| SCHEMBL1014426 | 0.78 | CA1 (0.37) | CA1CA2CA12CA9NAAA | |
| SCHEMBL30838782 | 0.78 | CA1 (0.37) | CA1CA2CA12CA9NAAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2010111406-A2 | COMPOUNDS AND THERAPEUTIC USES THEREOF | MYRIAD PHARMACEUTICALS, INC. (US) | 2010-09-30 | — | — | WO | disclosed |